

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nucleotide transmembrane transport (GO:1901679) | 4.44798758 |
| 2 | fatty acid elongation (GO:0030497) | 4.28120613 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 4.21431788 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 4.21431788 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.21431788 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.21431788 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.21431788 |
| 8 | modulation by symbiont of host immune response (GO:0052553) | 4.21431788 |
| 9 | signal peptide processing (GO:0006465) | 3.91576489 |
| 10 | protein complex biogenesis (GO:0070271) | 3.67399089 |
| 11 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.67237237 |
| 12 | NADH dehydrogenase complex assembly (GO:0010257) | 3.67237237 |
| 13 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.67237237 |
| 14 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.64832474 |
| 15 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.47566071 |
| 16 | respiratory chain complex IV assembly (GO:0008535) | 3.43145843 |
| 17 | response to peptidoglycan (GO:0032494) | 3.39950784 |
| 18 | axon ensheathment in central nervous system (GO:0032291) | 3.35324433 |
| 19 | central nervous system myelination (GO:0022010) | 3.35324433 |
| 20 | mannosylation (GO:0097502) | 3.32748847 |
| 21 | GPI anchor biosynthetic process (GO:0006506) | 3.29977544 |
| 22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.29194001 |
| 23 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.25554679 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 3.22810367 |
| 25 | aldehyde catabolic process (GO:0046185) | 3.22175306 |
| 26 | negative regulation of interleukin-12 production (GO:0032695) | 3.21647493 |
| 27 | immunoglobulin mediated immune response (GO:0016064) | 3.21472261 |
| 28 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.17790514 |
| 29 | artery smooth muscle contraction (GO:0014824) | 3.14417742 |
| 30 | ATP synthesis coupled proton transport (GO:0015986) | 3.12030931 |
| 31 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.12030931 |
| 32 | glucuronate metabolic process (GO:0019585) | 3.11844021 |
| 33 | uronic acid metabolic process (GO:0006063) | 3.11844021 |
| 34 | amyloid precursor protein catabolic process (GO:0042987) | 3.10164108 |
| 35 | cholesterol biosynthetic process (GO:0006695) | 3.09907096 |
| 36 | respiratory burst (GO:0045730) | 3.08155168 |
| 37 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.05917414 |
| 38 | respiratory electron transport chain (GO:0022904) | 3.02947076 |
| 39 | negative regulation of interleukin-1 production (GO:0032692) | 3.00938078 |
| 40 | electron transport chain (GO:0022900) | 2.99260890 |
| 41 | nucleotide transport (GO:0006862) | 2.97961414 |
| 42 | negative regulation of interleukin-1 beta production (GO:0032691) | 2.97800134 |
| 43 | cytochrome complex assembly (GO:0017004) | 2.97602941 |
| 44 | neutrophil activation (GO:0042119) | 2.97238973 |
| 45 | GPI anchor metabolic process (GO:0006505) | 2.95042656 |
| 46 | cellular glucuronidation (GO:0052695) | 2.92739936 |
| 47 | microglial cell activation (GO:0001774) | 2.91014903 |
| 48 | phagosome maturation (GO:0090382) | 2.90776827 |
| 49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.88367080 |
| 50 | positive regulation of cellular amine metabolic process (GO:0033240) | 2.87737877 |
| 51 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.87718477 |
| 52 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.87069866 |
| 53 | granulocyte activation (GO:0036230) | 2.86524118 |
| 54 | response to interferon-beta (GO:0035456) | 2.86209036 |
| 55 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.86171913 |
| 56 | B cell mediated immunity (GO:0019724) | 2.84221407 |
| 57 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.83168250 |
| 58 | detection of molecule of bacterial origin (GO:0032490) | 2.83130185 |
| 59 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.83064275 |
| 60 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.83064275 |
| 61 | regulation of metalloenzyme activity (GO:0048552) | 2.82837346 |
| 62 | amyloid precursor protein metabolic process (GO:0042982) | 2.80143496 |
| 63 | L-methionine salvage (GO:0071267) | 2.79712245 |
| 64 | L-methionine biosynthetic process (GO:0071265) | 2.79712245 |
| 65 | amino acid salvage (GO:0043102) | 2.79712245 |
| 66 | sterol biosynthetic process (GO:0016126) | 2.78208365 |
| 67 | GDP-mannose metabolic process (GO:0019673) | 2.77495212 |
| 68 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.75659636 |
| 69 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.74353445 |
| 70 | protein neddylation (GO:0045116) | 2.73935070 |
| 71 | response to redox state (GO:0051775) | 2.73403951 |
| 72 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.72931055 |
| 73 | superoxide anion generation (GO:0042554) | 2.72700980 |
| 74 | histamine secretion (GO:0001821) | 2.72176388 |
| 75 | positive regulation of interferon-alpha production (GO:0032727) | 2.72016507 |
| 76 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.71885698 |
| 77 | L-phenylalanine catabolic process (GO:0006559) | 2.71885698 |
| 78 | xenobiotic catabolic process (GO:0042178) | 2.69826216 |
| 79 | regulation of interferon-alpha production (GO:0032647) | 2.68065802 |
| 80 | cellular response to leptin stimulus (GO:0044320) | 2.66753184 |
| 81 | isoprenoid biosynthetic process (GO:0008299) | 2.66291854 |
| 82 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.63617523 |
| 83 | chaperone-mediated protein transport (GO:0072321) | 2.63234020 |
| 84 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.62628468 |
| 85 | protein deneddylation (GO:0000338) | 2.59254431 |
| 86 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.57810879 |
| 87 | dolichol-linked oligosaccharide biosynthetic process (GO:0006488) | 2.56479839 |
| 88 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.55205305 |
| 89 | C-terminal protein lipidation (GO:0006501) | 2.55118606 |
| 90 | sequestering of actin monomers (GO:0042989) | 2.52209404 |
| 91 | tonic smooth muscle contraction (GO:0014820) | 2.50849218 |
| 92 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.50372717 |
| 93 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.48486586 |
| 94 | negative regulation of ligase activity (GO:0051352) | 2.48486586 |
| 95 | cullin deneddylation (GO:0010388) | 2.48075712 |
| 96 | negative regulation of cell killing (GO:0031342) | 2.46770939 |
| 97 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.46770939 |
| 98 | peptidyl-histidine modification (GO:0018202) | 2.45521004 |
| 99 | neutrophil mediated immunity (GO:0002446) | 2.45044830 |
| 100 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.44874488 |
| 101 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.44671673 |
| 102 | glyoxylate metabolic process (GO:0046487) | 2.43292068 |
| 103 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 2.42857009 |
| 104 | pantothenate metabolic process (GO:0015939) | 2.42743470 |
| 105 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.42539095 |
| 106 | glutathione biosynthetic process (GO:0006750) | 2.42417840 |
| 107 | proteasome assembly (GO:0043248) | 2.42270926 |
| 108 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.42071032 |
| 109 | response to host immune response (GO:0052572) | 2.41783621 |
| 110 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.41783621 |
| 111 | detection of other organism (GO:0098543) | 2.41751471 |
| 112 | detection of external biotic stimulus (GO:0098581) | 2.40774398 |
| 113 | regulation of cilium movement (GO:0003352) | 2.39274923 |
| 114 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.39142657 |
| 115 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.39142657 |
| 116 | carbohydrate derivative transport (GO:1901264) | 2.38914473 |
| 117 | nonribosomal peptide biosynthetic process (GO:0019184) | 2.37066641 |
| 118 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.36654351 |
| 119 | L-phenylalanine metabolic process (GO:0006558) | 2.36654351 |
| 120 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.36176288 |
| 121 | sulfur amino acid catabolic process (GO:0000098) | 2.35659518 |
| 122 | ER overload response (GO:0006983) | 2.35178571 |
| 123 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.35127896 |
| 124 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.35127896 |
| 125 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.34634695 |
| 126 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.32937928 |
| 127 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.32937928 |
| 128 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.32937928 |
| 129 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.32357534 |
| 130 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.32357534 |
| 131 | myeloid leukocyte mediated immunity (GO:0002444) | 2.32007144 |
| 132 | regulation of cellular amine metabolic process (GO:0033238) | 2.31864542 |
| 133 | positive regulation of interleukin-17 production (GO:0032740) | 2.31327793 |
| 134 | regulation of regulatory T cell differentiation (GO:0045589) | 2.31087240 |
| 135 | interferon-gamma secretion (GO:0072643) | 2.30859333 |
| 136 | positive regulation of interferon-beta production (GO:0032728) | 2.30225578 |
| 137 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.29563560 |
| 138 | myeloid cell activation involved in immune response (GO:0002275) | 2.29143689 |
| 139 | positive regulation of interleukin-10 production (GO:0032733) | 2.28787420 |
| 140 | vascular smooth muscle contraction (GO:0014829) | 2.28763250 |
| 141 | negative regulation of acute inflammatory response (GO:0002674) | 2.27460270 |
| 142 | sphingomyelin metabolic process (GO:0006684) | 2.25455532 |
| 143 | sphingoid metabolic process (GO:0046519) | 2.25142157 |
| 144 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.25133286 |
| 145 | eye photoreceptor cell differentiation (GO:0001754) | 2.25015077 |
| 146 | photoreceptor cell differentiation (GO:0046530) | 2.25015077 |
| 147 | cofactor catabolic process (GO:0051187) | 2.24970771 |
| 148 | regulation of cytokine secretion involved in immune response (GO:0002739) | 2.24847057 |
| 149 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.24538990 |
| 150 | hydrogen peroxide catabolic process (GO:0042744) | 2.24427947 |
| 151 | detection of bacterium (GO:0016045) | 2.24089328 |
| 152 | phagocytosis, engulfment (GO:0006911) | 2.24061388 |
| 153 | cellular response to interferon-beta (GO:0035458) | 2.23797251 |
| 154 | very long-chain fatty acid metabolic process (GO:0000038) | 2.23208500 |
| 155 | leukocyte aggregation (GO:0070486) | 2.23114489 |
| 156 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.21976037 |
| 157 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.21279803 |
| 158 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.21076106 |
| 159 | termination of RNA polymerase III transcription (GO:0006386) | 2.21076106 |
| 160 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.20748395 |
| 161 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.20238656 |
| 162 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.20148564 |
| 163 | neutrophil activation involved in immune response (GO:0002283) | 2.19708968 |
| 164 | glutathione derivative metabolic process (GO:1901685) | 2.18936020 |
| 165 | glutathione derivative biosynthetic process (GO:1901687) | 2.18936020 |
| 166 | negative regulation of chemokine production (GO:0032682) | 2.18803658 |
| 167 | aromatic amino acid family catabolic process (GO:0009074) | 2.18685514 |
| 168 | purine ribonucleotide transport (GO:0015868) | 2.18344089 |
| 169 | opsonization (GO:0008228) | 2.17864518 |
| 170 | C-terminal protein amino acid modification (GO:0018410) | 2.15747090 |
| 171 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.15292598 |
| 172 | intracellular pH reduction (GO:0051452) | 2.15044789 |
| 173 | glutathione metabolic process (GO:0006749) | 2.14072218 |
| 174 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.13945699 |
| 175 | ribosomal small subunit assembly (GO:0000028) | 2.13433331 |
| 176 | regulation of antigen processing and presentation (GO:0002577) | 2.13277600 |
| 177 | aerobic respiration (GO:0009060) | 2.13190540 |
| 178 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.12912915 |
| 179 | pH reduction (GO:0045851) | 2.12690159 |
| 180 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.11498636 |
| 181 | proton transport (GO:0015992) | 2.11470441 |
| 182 | fucose metabolic process (GO:0006004) | 2.11227619 |
| 183 | sulfation (GO:0051923) | 2.10483501 |
| 184 | nucleotide-sugar metabolic process (GO:0009225) | 2.09417874 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.44933073 |
| 2 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 4.26923247 |
| 3 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.76993345 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.64078691 |
| 5 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.63623670 |
| 6 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.62257027 |
| 7 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.50627858 |
| 8 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.46036133 |
| 9 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.43873384 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.37957119 |
| 11 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.23450760 |
| 12 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.22964832 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.21658683 |
| 14 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.20268371 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.08582617 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.05917583 |
| 17 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.04501965 |
| 18 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.01097591 |
| 19 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.98069306 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.91690470 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87093623 |
| 22 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.86866876 |
| 23 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.83454203 |
| 24 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.80060751 |
| 25 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.80044791 |
| 26 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.78166289 |
| 27 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.70313144 |
| 28 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.64997278 |
| 29 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.64018486 |
| 30 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.63718445 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.61896577 |
| 32 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.61621062 |
| 33 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.61074970 |
| 34 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.60620624 |
| 35 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.56002265 |
| 36 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.54552664 |
| 37 | VDR_22108803_ChIP-Seq_LS180_Human | 1.54315789 |
| 38 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52491657 |
| 39 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.52260000 |
| 40 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.50280381 |
| 41 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.48681170 |
| 42 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.45823207 |
| 43 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.45508994 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42848462 |
| 45 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.40668054 |
| 46 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40555734 |
| 47 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.38650279 |
| 48 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.34511114 |
| 49 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.34263279 |
| 50 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.32127910 |
| 51 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.30307306 |
| 52 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.29819142 |
| 53 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.28455549 |
| 54 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27757056 |
| 55 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.25357349 |
| 56 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.22543470 |
| 57 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.22257970 |
| 58 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20479517 |
| 59 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.19420551 |
| 60 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.19172393 |
| 61 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.19172393 |
| 62 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.19172393 |
| 63 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.19083446 |
| 64 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.16377789 |
| 65 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.15140462 |
| 66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14918536 |
| 67 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.13507429 |
| 68 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11950779 |
| 69 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.11878842 |
| 70 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11139357 |
| 71 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.10803474 |
| 72 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.10796706 |
| 73 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.10728860 |
| 74 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10484133 |
| 75 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.10282061 |
| 76 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.09723196 |
| 77 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.09248988 |
| 78 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08092999 |
| 79 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.08073750 |
| 80 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.07809189 |
| 81 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.07498374 |
| 82 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.07071547 |
| 83 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.07014712 |
| 84 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.06994274 |
| 85 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.06354429 |
| 86 | AR_20517297_ChIP-Seq_VCAP_Human | 1.05906534 |
| 87 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.05185886 |
| 88 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.04860500 |
| 89 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.04716272 |
| 90 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.04216917 |
| 91 | * EOMES_21245162_ChIP-Seq_HESCs_Human | 1.03500313 |
| 92 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03482514 |
| 93 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.03358364 |
| 94 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.03206220 |
| 95 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.03173476 |
| 96 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.02618486 |
| 97 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.02351279 |
| 98 | GATA3_26560356_Chip-Seq_TH2_Human | 1.01233682 |
| 99 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.01018605 |
| 100 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.00868350 |
| 101 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.00549179 |
| 102 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.99698697 |
| 103 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.98882942 |
| 104 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.98469411 |
| 105 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.97832064 |
| 106 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.97054281 |
| 107 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.97054281 |
| 108 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95986672 |
| 109 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95621776 |
| 110 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.95424396 |
| 111 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.95245243 |
| 112 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.94918688 |
| 113 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.94906707 |
| 114 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.94073719 |
| 115 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92542588 |
| 116 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.92282371 |
| 117 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92192947 |
| 118 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.91893362 |
| 119 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.91779458 |
| 120 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.90721033 |
| 121 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.90670926 |
| 122 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.90632826 |
| 123 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.90554827 |
| 124 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.90343611 |
| 125 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.90187334 |
| 126 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.90067284 |
| 127 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.90039349 |
| 128 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.90039349 |
| 129 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.89953979 |
| 130 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.89674489 |
| 131 | MYB_26560356_Chip-Seq_TH2_Human | 0.89114499 |
| 132 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.89017344 |
| 133 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.88987619 |
| 134 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.88893913 |
| 135 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.88865039 |
| 136 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.88862750 |
| 137 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.88712205 |
| 138 | P300_19829295_ChIP-Seq_ESCs_Human | 0.88605959 |
| 139 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 0.87911389 |
| 140 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87790529 |
| 141 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.87622538 |
| 142 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.87408118 |
| 143 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.87094140 |
| 144 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.86404337 |
| 145 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.86050119 |
| 146 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.85430998 |
| 147 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.84864576 |
| 148 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.84519018 |
| 149 | SPI1_23127762_ChIP-Seq_K562_Human | 0.84078862 |
| 150 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.84049886 |
| 151 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 0.84009810 |
| 152 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83650085 |
| 153 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.82172931 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001986_abnormal_taste_sensitivity | 3.34433294 |
| 2 | MP0008875_abnormal_xenobiotic_pharmacok | 2.54468680 |
| 3 | MP0002876_abnormal_thyroid_physiology | 2.54200550 |
| 4 | MP0009379_abnormal_foot_pigmentation | 2.42008387 |
| 5 | MP0001835_abnormal_antigen_presentation | 2.38820902 |
| 6 | MP0002139_abnormal_hepatobiliary_system | 2.34933899 |
| 7 | MP0005360_urolithiasis | 2.28616581 |
| 8 | MP0003303_peritoneal_inflammation | 2.26117855 |
| 9 | MP0009785_altered_susceptibility_to | 2.22494314 |
| 10 | MP0003195_calcinosis | 2.18188648 |
| 11 | MP0003724_increased_susceptibility_to | 2.12273596 |
| 12 | MP0001905_abnormal_dopamine_level | 2.07910106 |
| 13 | MP0005451_abnormal_body_composition | 2.02892818 |
| 14 | MP0002822_catalepsy | 1.98569835 |
| 15 | MP0002148_abnormal_hypersensitivity_rea | 1.94196791 |
| 16 | MP0006082_CNS_inflammation | 1.92349889 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 1.89456810 |
| 18 | MP0005085_abnormal_gallbladder_physiolo | 1.88298425 |
| 19 | MP0005671_abnormal_response_to | 1.83046710 |
| 20 | MP0009278_abnormal_bone_marrow | 1.82627274 |
| 21 | MP0008260_abnormal_autophagy | 1.81103938 |
| 22 | MP0001666_abnormal_nutrient_absorption | 1.77826483 |
| 23 | MP0000685_abnormal_immune_system | 1.76135403 |
| 24 | MP0005310_abnormal_salivary_gland | 1.75714520 |
| 25 | MP0001529_abnormal_vocalization | 1.70784673 |
| 26 | MP0004134_abnormal_chest_morphology | 1.70178175 |
| 27 | MP0001542_abnormal_bone_strength | 1.69635287 |
| 28 | MP0000343_altered_response_to | 1.65215533 |
| 29 | MP0003186_abnormal_redox_activity | 1.65053930 |
| 30 | MP0005365_abnormal_bile_salt | 1.62425898 |
| 31 | MP0010386_abnormal_urinary_bladder | 1.61327898 |
| 32 | MP0002132_abnormal_respiratory_system | 1.60036316 |
| 33 | MP0005058_abnormal_lysosome_morphology | 1.59474322 |
| 34 | MP0000920_abnormal_myelination | 1.54342949 |
| 35 | MP0001873_stomach_inflammation | 1.54053569 |
| 36 | MP0005025_abnormal_response_to | 1.53863697 |
| 37 | MP0004147_increased_porphyrin_level | 1.50377272 |
| 38 | MP0005000_abnormal_immune_tolerance | 1.48178123 |
| 39 | MP0002933_joint_inflammation | 1.46488459 |
| 40 | MP0005387_immune_system_phenotype | 1.45611972 |
| 41 | MP0001790_abnormal_immune_system | 1.45611972 |
| 42 | MP0005645_abnormal_hypothalamus_physiol | 1.44722438 |
| 43 | MP0001764_abnormal_homeostasis | 1.44576433 |
| 44 | MP0004381_abnormal_hair_follicle | 1.43711579 |
| 45 | MP0003868_abnormal_feces_composition | 1.43124848 |
| 46 | MP0002419_abnormal_innate_immunity | 1.40614830 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.33337234 |
| 48 | MP0004019_abnormal_vitamin_homeostasis | 1.32107723 |
| 49 | MP0005379_endocrine/exocrine_gland_phen | 1.31875801 |
| 50 | MP0004043_abnormal_pH_regulation | 1.30885925 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.30707909 |
| 52 | MP0003866_abnormal_defecation | 1.30025198 |
| 53 | MP0003436_decreased_susceptibility_to | 1.28846160 |
| 54 | MP0002090_abnormal_vision | 1.27255223 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.26516996 |
| 56 | MP0005332_abnormal_amino_acid | 1.25979906 |
| 57 | MP0005166_decreased_susceptibility_to | 1.25437617 |
| 58 | MP0005636_abnormal_mineral_homeostasis | 1.23330847 |
| 59 | MP0001663_abnormal_digestive_system | 1.22892803 |
| 60 | MP0002277_abnormal_respiratory_mucosa | 1.22719137 |
| 61 | MP0006035_abnormal_mitochondrial_morpho | 1.21588180 |
| 62 | MP0002723_abnormal_immune_serum | 1.20647897 |
| 63 | MP0000465_gastrointestinal_hemorrhage | 1.19653736 |
| 64 | MP0005381_digestive/alimentary_phenotyp | 1.19001998 |
| 65 | MP0003300_gastrointestinal_ulcer | 1.18581571 |
| 66 | MP0001800_abnormal_humoral_immune | 1.18299525 |
| 67 | MP0009840_abnormal_foam_cell | 1.15747403 |
| 68 | MP0003075_altered_response_to | 1.15710647 |
| 69 | MP0003183_abnormal_peptide_metabolism | 1.15354482 |
| 70 | MP0004142_abnormal_muscle_tone | 1.13785954 |
| 71 | MP0004883_abnormal_blood_vessel | 1.13249840 |
| 72 | MP0009765_abnormal_xenobiotic_induced | 1.12899134 |
| 73 | MP0005464_abnormal_platelet_physiology | 1.12405181 |
| 74 | MP0002452_abnormal_antigen_presenting | 1.12124301 |
| 75 | MP0009697_abnormal_copulation | 1.11305035 |
| 76 | MP0008469_abnormal_protein_level | 1.10680564 |
| 77 | MP0005084_abnormal_gallbladder_morpholo | 1.10474400 |
| 78 | MP0001188_hyperpigmentation | 1.08989622 |
| 79 | MP0002163_abnormal_gland_morphology | 1.08508993 |
| 80 | MP0003136_yellow_coat_color | 1.08384464 |
| 81 | MP0001664_abnormal_digestion | 1.08056085 |
| 82 | MP0003828_pulmonary_edema | 1.07672087 |
| 83 | MP0000604_amyloidosis | 1.06766421 |
| 84 | MP0008789_abnormal_olfactory_epithelium | 1.06747648 |
| 85 | MP0000858_altered_metastatic_potential | 1.06453126 |
| 86 | MP0002254_reproductive_system_inflammat | 1.06247607 |
| 87 | MP0004742_abnormal_vestibular_system | 1.05748014 |
| 88 | MP0004782_abnormal_surfactant_physiolog | 1.05304997 |
| 89 | MP0009643_abnormal_urine_homeostasis | 1.04181536 |
| 90 | MP0001853_heart_inflammation | 1.03712472 |
| 91 | MP0003690_abnormal_glial_cell | 1.03078358 |
| 92 | MP0002420_abnormal_adaptive_immunity | 1.02614694 |
| 93 | MP0001533_abnormal_skeleton_physiology | 1.02404217 |
| 94 | MP0009384_cardiac_valve_regurgitation | 1.01886187 |
| 95 | MP0001819_abnormal_immune_cell | 1.01771946 |
| 96 | MP0001984_abnormal_olfaction | 1.01001516 |
| 97 | MP0005394_taste/olfaction_phenotype | 1.00815394 |
| 98 | MP0005499_abnormal_olfactory_system | 1.00815394 |
| 99 | MP0010155_abnormal_intestine_physiology | 0.99836333 |
| 100 | MP0001845_abnormal_inflammatory_respons | 0.99306093 |
| 101 | MP0003011_delayed_dark_adaptation | 0.99197536 |
| 102 | MP0003656_abnormal_erythrocyte_physiolo | 0.98159767 |
| 103 | MP0003329_amyloid_beta_deposits | 0.96166394 |
| 104 | MP0005075_abnormal_melanosome_morpholog | 0.95601399 |
| 105 | MP0005408_hypopigmentation | 0.95225840 |
| 106 | MP0005319_abnormal_enzyme/_coenzyme | 0.95004208 |
| 107 | MP0008004_abnormal_stomach_pH | 0.94908896 |
| 108 | MP0000372_irregular_coat_pigmentation | 0.94642034 |
| 109 | MP0005377_hearing/vestibular/ear_phenot | 0.93419955 |
| 110 | MP0003878_abnormal_ear_physiology | 0.93419955 |
| 111 | MP0004947_skin_inflammation | 0.91843800 |
| 112 | MP0005164_abnormal_response_to | 0.91382067 |
| 113 | MP0004264_abnormal_extraembryonic_tissu | 0.90359145 |
| 114 | MP0009763_increased_sensitivity_to | 0.89653645 |
| 115 | MP0000716_abnormal_immune_system | 0.88111310 |
| 116 | MP0005551_abnormal_eye_electrophysiolog | 0.87361599 |
| 117 | MP0002166_altered_tumor_susceptibility | 0.86928285 |
| 118 | MP0000462_abnormal_digestive_system | 0.86462606 |
| 119 | MP0002405_respiratory_system_inflammati | 0.86421126 |
| 120 | MP0009333_abnormal_splenocyte_physiolog | 0.85774689 |
| 121 | MP0005083_abnormal_biliary_tract | 0.85096624 |
| 122 | MP0001346_abnormal_lacrimal_gland | 0.84840955 |
| 123 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.84715798 |
| 124 | MP0005220_abnormal_exocrine_pancreas | 0.84497356 |
| 125 | MP0003448_altered_tumor_morphology | 0.83961838 |
| 126 | MP0001727_abnormal_embryo_implantation | 0.83900758 |
| 127 | MP0006036_abnormal_mitochondrial_physio | 0.83351063 |
| 128 | MP0000609_abnormal_liver_physiology | 0.82969447 |
| 129 | MP0009764_decreased_sensitivity_to | 0.82139755 |
| 130 | MP0000490_abnormal_crypts_of | 0.80751805 |
| 131 | MP0002653_abnormal_ependyma_morphology | 0.78559944 |
| 132 | MP0000358_abnormal_cell_content/ | 0.77612160 |
| 133 | MP0003221_abnormal_cardiomyocyte_apopto | 0.73457374 |
| 134 | MP0005397_hematopoietic_system_phenotyp | 0.73013251 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of macrophages (HP:0004311) | 3.94332983 |
| 2 | Acute necrotizing encephalopathy (HP:0006965) | 3.76877549 |
| 3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.76745047 |
| 4 | Mitochondrial inheritance (HP:0001427) | 3.50317941 |
| 5 | Myositis (HP:0100614) | 3.46638056 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.42838277 |
| 7 | Hepatocellular necrosis (HP:0001404) | 3.42833711 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.36868981 |
| 9 | Irregular epiphyses (HP:0010582) | 3.35432001 |
| 10 | Loss of speech (HP:0002371) | 3.34273718 |
| 11 | Acute encephalopathy (HP:0006846) | 3.24748530 |
| 12 | 3-Methylglutaconic aciduria (HP:0003535) | 3.21337146 |
| 13 | Hepatic necrosis (HP:0002605) | 3.20400992 |
| 14 | Abnormal tarsal ossification (HP:0008369) | 3.07785491 |
| 15 | Spontaneous hematomas (HP:0007420) | 3.06491231 |
| 16 | Orchitis (HP:0100796) | 3.01900003 |
| 17 | Renal Fanconi syndrome (HP:0001994) | 3.00877377 |
| 18 | Abnormality of glycolipid metabolism (HP:0010969) | 2.98242945 |
| 19 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.98242945 |
| 20 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.98242945 |
| 21 | Progressive macrocephaly (HP:0004481) | 2.94031637 |
| 22 | Retrobulbar optic neuritis (HP:0100654) | 2.89260845 |
| 23 | Optic neuritis (HP:0100653) | 2.89260845 |
| 24 | Increased CSF lactate (HP:0002490) | 2.88922195 |
| 25 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.84443008 |
| 26 | Parakeratosis (HP:0001036) | 2.80065113 |
| 27 | Epiphyseal dysplasia (HP:0002656) | 2.73340633 |
| 28 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.73193692 |
| 29 | Episodic fever (HP:0001954) | 2.67354821 |
| 30 | Type I transferrin isoform profile (HP:0003642) | 2.64838177 |
| 31 | Small epiphyses (HP:0010585) | 2.64539513 |
| 32 | Increased hepatocellular lipid droplets (HP:0006565) | 2.63304615 |
| 33 | Systemic lupus erythematosus (HP:0002725) | 2.63130855 |
| 34 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.56591291 |
| 35 | Reduced antithrombin III activity (HP:0001976) | 2.50974423 |
| 36 | Delayed epiphyseal ossification (HP:0002663) | 2.48871622 |
| 37 | Lipid accumulation in hepatocytes (HP:0006561) | 2.48793993 |
| 38 | Vacuolated lymphocytes (HP:0001922) | 2.48119730 |
| 39 | Beaking of vertebral bodies (HP:0004568) | 2.43425742 |
| 40 | Mutism (HP:0002300) | 2.42382819 |
| 41 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.42006559 |
| 42 | Flat capital femoral epiphysis (HP:0003370) | 2.38157403 |
| 43 | Cerebral edema (HP:0002181) | 2.37284937 |
| 44 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.36890564 |
| 45 | Hypothermia (HP:0002045) | 2.35204473 |
| 46 | Prolonged partial thromboplastin time (HP:0003645) | 2.30649236 |
| 47 | Chronic obstructive pulmonary disease (HP:0006510) | 2.29103722 |
| 48 | Obstructive lung disease (HP:0006536) | 2.29103722 |
| 49 | Metaphyseal irregularity (HP:0003025) | 2.27940198 |
| 50 | Abnormal protein glycosylation (HP:0012346) | 2.27933921 |
| 51 | Abnormal glycosylation (HP:0012345) | 2.27933921 |
| 52 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.27933921 |
| 53 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.27933921 |
| 54 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.23488940 |
| 55 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.23488940 |
| 56 | Increased serum pyruvate (HP:0003542) | 2.22711653 |
| 57 | Abnormality of glycolysis (HP:0004366) | 2.22711653 |
| 58 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 2.20124794 |
| 59 | Anorexia (HP:0002039) | 2.18805738 |
| 60 | Polyphagia (HP:0002591) | 2.17979372 |
| 61 | Abnormality of renal resorption (HP:0011038) | 2.16171596 |
| 62 | Purpura (HP:0000979) | 2.15616804 |
| 63 | Increased serum lactate (HP:0002151) | 2.12825374 |
| 64 | Encephalitis (HP:0002383) | 2.12706916 |
| 65 | Cupped ribs (HP:0000887) | 2.12578554 |
| 66 | Lactic acidosis (HP:0003128) | 2.12484088 |
| 67 | Increased intramyocellular lipid droplets (HP:0012240) | 2.11904968 |
| 68 | Respiratory failure (HP:0002878) | 2.11687880 |
| 69 | Abnormality of the vertebral endplates (HP:0005106) | 2.11538169 |
| 70 | Petechiae (HP:0000967) | 2.10423270 |
| 71 | Optic disc pallor (HP:0000543) | 2.10187501 |
| 72 | Short femoral neck (HP:0100864) | 2.10158508 |
| 73 | Steatorrhea (HP:0002570) | 2.09758204 |
| 74 | Leukodystrophy (HP:0002415) | 2.08059575 |
| 75 | Amyloidosis (HP:0011034) | 2.07173794 |
| 76 | Microretrognathia (HP:0000308) | 2.06663905 |
| 77 | Prolonged neonatal jaundice (HP:0006579) | 2.05169776 |
| 78 | Exertional dyspnea (HP:0002875) | 2.05134470 |
| 79 | Genu varum (HP:0002970) | 2.04310504 |
| 80 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.04177725 |
| 81 | Abolished electroretinogram (ERG) (HP:0000550) | 2.03147814 |
| 82 | Urticaria (HP:0001025) | 2.01920872 |
| 83 | Fat malabsorption (HP:0002630) | 2.01110844 |
| 84 | Generalized aminoaciduria (HP:0002909) | 1.99531341 |
| 85 | Congenital primary aphakia (HP:0007707) | 1.99362588 |
| 86 | Gait imbalance (HP:0002141) | 1.98424879 |
| 87 | CNS demyelination (HP:0007305) | 1.96142587 |
| 88 | Increased cerebral lipofuscin (HP:0011813) | 1.95959697 |
| 89 | Irregular vertebral endplates (HP:0003301) | 1.95429252 |
| 90 | Medial flaring of the eyebrow (HP:0010747) | 1.94961449 |
| 91 | Abnormality of the femoral head (HP:0003368) | 1.94880064 |
| 92 | Vaginal fistula (HP:0004320) | 1.94455784 |
| 93 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.94408982 |
| 94 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.92716384 |
| 95 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.92716384 |
| 96 | Sensorimotor neuropathy (HP:0007141) | 1.90737577 |
| 97 | Glycosuria (HP:0003076) | 1.90022482 |
| 98 | Abnormality of urine glucose concentration (HP:0011016) | 1.90022482 |
| 99 | Abnormal foot bone ossification (HP:0010675) | 1.89127796 |
| 100 | Rectovaginal fistula (HP:0000143) | 1.89015537 |
| 101 | Rectal fistula (HP:0100590) | 1.89015537 |
| 102 | Thyroid-stimulating hormone excess (HP:0002925) | 1.88605512 |
| 103 | Intrahepatic cholestasis (HP:0001406) | 1.87764641 |
| 104 | Conjugated hyperbilirubinemia (HP:0002908) | 1.87681647 |
| 105 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.86752424 |
| 106 | Disinhibition (HP:0000734) | 1.86659225 |
| 107 | Abnormality of carpal bone ossification (HP:0006257) | 1.86511618 |
| 108 | Recurrent bacterial skin infections (HP:0005406) | 1.86210354 |
| 109 | Mediastinal lymphadenopathy (HP:0100721) | 1.85270652 |
| 110 | Hepatosplenomegaly (HP:0001433) | 1.85221475 |
| 111 | Hyperammonemia (HP:0001987) | 1.85070700 |
| 112 | Recurrent abscess formation (HP:0002722) | 1.84805414 |
| 113 | Increased muscle lipid content (HP:0009058) | 1.84784751 |
| 114 | Abnormality of alanine metabolism (HP:0010916) | 1.84518829 |
| 115 | Hyperalaninemia (HP:0003348) | 1.84518829 |
| 116 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.84518829 |
| 117 | Hypoplasia of the uterus (HP:0000013) | 1.84501808 |
| 118 | Lethargy (HP:0001254) | 1.83733483 |
| 119 | Microvesicular hepatic steatosis (HP:0001414) | 1.83458892 |
| 120 | Hypochromic microcytic anemia (HP:0004840) | 1.83341792 |
| 121 | Delayed CNS myelination (HP:0002188) | 1.83267162 |
| 122 | Increased IgM level (HP:0003496) | 1.82702433 |
| 123 | Stenosis of the external auditory canal (HP:0000402) | 1.81176339 |
| 124 | Recurrent skin infections (HP:0001581) | 1.80491700 |
| 125 | Short tibia (HP:0005736) | 1.80402632 |
| 126 | Hypobetalipoproteinemia (HP:0003563) | 1.79294308 |
| 127 | Exercise intolerance (HP:0003546) | 1.79291794 |
| 128 | Pancreatitis (HP:0001733) | 1.78658078 |
| 129 | Abnormality of the epiphysis of the femoral head (HP:0010574) | 1.78310810 |
| 130 | Hematochezia (HP:0002573) | 1.78039336 |
| 131 | Irritability (HP:0000737) | 1.76238416 |
| 132 | Autoamputation (HP:0001218) | 1.75713432 |
| 133 | Flattened epiphyses (HP:0003071) | 1.75593812 |
| 134 | IgM deficiency (HP:0002850) | 1.70853313 |
| 135 | Eczematoid dermatitis (HP:0000976) | 1.70684197 |
| 136 | Barrel-shaped chest (HP:0001552) | 1.69687159 |
| 137 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.69512427 |
| 138 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.69382063 |
| 139 | Abnormality of serum amino acid levels (HP:0003112) | 1.68942470 |
| 140 | Microcytic anemia (HP:0001935) | 1.68374116 |
| 141 | Abnormality involving the epiphyses of the lower limbs (HP:0006500) | 1.68238721 |
| 142 | Abnormality of femoral epiphyses (HP:0006499) | 1.68238721 |
| 143 | Disproportionate short-trunk short stature (HP:0003521) | 1.67008403 |
| 144 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.66979889 |
| 145 | Hypergammaglobulinemia (HP:0010702) | 1.66882905 |
| 146 | Progressive neurologic deterioration (HP:0002344) | 1.66209865 |
| 147 | Ovoid vertebral bodies (HP:0003300) | 1.65696175 |
| 148 | Patchy hypopigmentation of hair (HP:0011365) | 1.65647802 |
| 149 | Hypokinesia (HP:0002375) | 1.65340788 |
| 150 | Spastic paraparesis (HP:0002313) | 1.64827469 |
| 151 | Pulmonary embolism (HP:0002204) | 1.64711341 |
| 152 | Vasculitis (HP:0002633) | 1.64142606 |
| 153 | Abnormal ciliary motility (HP:0012262) | 1.63757582 |
| 154 | Stomatitis (HP:0010280) | 1.63346151 |
| 155 | Hyperphosphaturia (HP:0003109) | 1.60164266 |
| 156 | Abnormality of the intrinsic pathway (HP:0010989) | 1.60049769 |
| 157 | Nephrogenic diabetes insipidus (HP:0009806) | 1.59769138 |
| 158 | Recurrent pneumonia (HP:0006532) | 1.59697049 |
| 159 | Congenital stationary night blindness (HP:0007642) | 1.59541213 |
| 160 | Abnormal pupillary function (HP:0007686) | 1.58600281 |
| 161 | Cerebral palsy (HP:0100021) | 1.58261516 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIM28 | 3.29035941 |
| 2 | MST4 | 3.16864557 |
| 3 | STK16 | 2.99310297 |
| 4 | PIM2 | 2.56346318 |
| 5 | STK39 | 2.43991404 |
| 6 | CASK | 2.41617370 |
| 7 | MAP3K11 | 2.30170261 |
| 8 | TNIK | 2.14411409 |
| 9 | OXSR1 | 2.10119814 |
| 10 | ARAF | 2.09767907 |
| 11 | NME1 | 2.08594425 |
| 12 | TESK1 | 2.05151986 |
| 13 | IRAK4 | 2.01724729 |
| 14 | NME2 | 2.01240553 |
| 15 | PBK | 1.94742988 |
| 16 | ADRBK2 | 1.83481433 |
| 17 | TXK | 1.80784807 |
| 18 | MAP3K12 | 1.76849578 |
| 19 | BLK | 1.75697898 |
| 20 | MAP3K14 | 1.74502093 |
| 21 | BMPR2 | 1.67794824 |
| 22 | MYLK | 1.58735300 |
| 23 | EPHB1 | 1.57580983 |
| 24 | MUSK | 1.55231881 |
| 25 | EIF2AK3 | 1.53813404 |
| 26 | ERN1 | 1.52474195 |
| 27 | GRK6 | 1.51941724 |
| 28 | GRK1 | 1.51709086 |
| 29 | MAP2K3 | 1.49581827 |
| 30 | IRAK3 | 1.48781988 |
| 31 | DYRK3 | 1.46510867 |
| 32 | NLK | 1.39041502 |
| 33 | TIE1 | 1.37979705 |
| 34 | MAP3K6 | 1.37474974 |
| 35 | MAP3K5 | 1.32183216 |
| 36 | MAPK15 | 1.30978793 |
| 37 | BMPR1B | 1.30012464 |
| 38 | EIF2AK1 | 1.27973751 |
| 39 | BCKDK | 1.25640702 |
| 40 | VRK1 | 1.25056625 |
| 41 | RIPK4 | 1.23166712 |
| 42 | TEC | 1.22578884 |
| 43 | CDK19 | 1.21543813 |
| 44 | TESK2 | 1.19811161 |
| 45 | PAK4 | 1.17434679 |
| 46 | BRAF | 1.15883571 |
| 47 | MAPKAPK3 | 1.12923849 |
| 48 | TYK2 | 1.12555814 |
| 49 | MAPKAPK5 | 1.11738532 |
| 50 | ERBB3 | 1.11404350 |
| 51 | BUB1 | 1.10975821 |
| 52 | MST1R | 1.09418340 |
| 53 | WNK4 | 1.07084493 |
| 54 | MAP2K4 | 1.05770625 |
| 55 | TAOK3 | 1.05725673 |
| 56 | BCR | 1.05557813 |
| 57 | NUAK1 | 1.04461163 |
| 58 | DAPK1 | 1.04111888 |
| 59 | PIK3CG | 1.03879211 |
| 60 | KIT | 1.03100559 |
| 61 | IKBKE | 1.02031994 |
| 62 | ACVR1B | 1.01154225 |
| 63 | PINK1 | 0.99541014 |
| 64 | IRAK1 | 0.99061208 |
| 65 | INSRR | 0.95827103 |
| 66 | NEK6 | 0.94269265 |
| 67 | SRPK1 | 0.92156028 |
| 68 | IKBKB | 0.91913853 |
| 69 | DYRK2 | 0.90846985 |
| 70 | CSNK1G3 | 0.88510118 |
| 71 | FER | 0.88097823 |
| 72 | TGFBR2 | 0.87936439 |
| 73 | EIF2AK2 | 0.84576632 |
| 74 | SYK | 0.83649468 |
| 75 | ZAK | 0.82599099 |
| 76 | CDK3 | 0.80209890 |
| 77 | KSR1 | 0.80183716 |
| 78 | LRRK2 | 0.80068548 |
| 79 | MAP4K1 | 0.79680967 |
| 80 | CCNB1 | 0.79249595 |
| 81 | BTK | 0.79208171 |
| 82 | MAP2K7 | 0.76814051 |
| 83 | LYN | 0.76735486 |
| 84 | FES | 0.76396562 |
| 85 | MAP2K2 | 0.75479384 |
| 86 | YES1 | 0.74828121 |
| 87 | ZAP70 | 0.74566031 |
| 88 | LIMK1 | 0.74538722 |
| 89 | STK10 | 0.74452647 |
| 90 | PRKCE | 0.74278509 |
| 91 | CAMK2B | 0.73336788 |
| 92 | TBK1 | 0.73179479 |
| 93 | GRK7 | 0.72858491 |
| 94 | PRKCQ | 0.72240849 |
| 95 | VRK2 | 0.70430071 |
| 96 | RPS6KA5 | 0.69285085 |
| 97 | WNK3 | 0.68662517 |
| 98 | CDK8 | 0.68585005 |
| 99 | CSNK1G2 | 0.68254524 |
| 100 | FGR | 0.67799634 |
| 101 | CAMK2G | 0.67461118 |
| 102 | CSNK1G1 | 0.65573454 |
| 103 | TAOK1 | 0.64810923 |
| 104 | ABL2 | 0.64492885 |
| 105 | CAMK2D | 0.63991560 |
| 106 | LCK | 0.62656267 |
| 107 | STK24 | 0.62398863 |
| 108 | PRKG2 | 0.61688377 |
| 109 | IRAK2 | 0.61479002 |
| 110 | CSF1R | 0.60932234 |
| 111 | AKT3 | 0.60135484 |
| 112 | PKN1 | 0.59435252 |
| 113 | JAK2 | 0.59165293 |
| 114 | MAP3K3 | 0.58530523 |
| 115 | ERBB4 | 0.58471544 |
| 116 | SIK3 | 0.57406142 |
| 117 | PDK2 | 0.56296969 |
| 118 | MAPKAPK2 | 0.54461808 |
| 119 | GRK5 | 0.53919067 |
| 120 | EPHA3 | 0.53572784 |
| 121 | MAP3K1 | 0.53081238 |
| 122 | MATK | 0.53055930 |
| 123 | TNK2 | 0.52721241 |
| 124 | HCK | 0.52235527 |
| 125 | MKNK1 | 0.52161719 |
| 126 | MAP2K6 | 0.52014437 |
| 127 | MINK1 | 0.51030032 |
| 128 | PRKCI | 0.50681956 |
| 129 | JAK1 | 0.50482138 |
| 130 | CSNK1A1L | 0.49004779 |
| 131 | MET | 0.48597271 |
| 132 | CSK | 0.48134069 |
| 133 | MAPK4 | 0.47018231 |
| 134 | MAP3K4 | 0.46931325 |
| 135 | PRKCD | 0.46748365 |
| 136 | MKNK2 | 0.45664252 |
| 137 | ITK | 0.44254403 |
| 138 | JAK3 | 0.43952055 |
| 139 | MAP4K2 | 0.41937850 |
| 140 | ALK | 0.41830592 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Protein export_Homo sapiens_hsa03060 | 3.58848795 |
| 2 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.38996982 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.19548301 |
| 4 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.61136768 |
| 5 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.44621819 |
| 6 | Parkinsons disease_Homo sapiens_hsa05012 | 2.33179778 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 2.23522611 |
| 8 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.17425543 |
| 9 | Histidine metabolism_Homo sapiens_hsa00340 | 2.16118089 |
| 10 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.96614181 |
| 11 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.91816941 |
| 12 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.88302820 |
| 13 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.84903598 |
| 14 | Alzheimers disease_Homo sapiens_hsa05010 | 1.83921591 |
| 15 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.76970971 |
| 16 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.71171743 |
| 17 | Ribosome_Homo sapiens_hsa03010 | 1.70822529 |
| 18 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.69449281 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.68181785 |
| 20 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.62843783 |
| 21 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.60115922 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.52583055 |
| 23 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.49936487 |
| 24 | Legionellosis_Homo sapiens_hsa05134 | 1.49183256 |
| 25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.45254721 |
| 26 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.43862317 |
| 27 | Huntingtons disease_Homo sapiens_hsa05016 | 1.43166760 |
| 28 | RNA polymerase_Homo sapiens_hsa03020 | 1.41376444 |
| 29 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.38105865 |
| 30 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.36989577 |
| 31 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.35202043 |
| 32 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.34777307 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.34738217 |
| 34 | Sulfur relay system_Homo sapiens_hsa04122 | 1.31529655 |
| 35 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.30731574 |
| 36 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.29975075 |
| 37 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.29371054 |
| 38 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.28942521 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.28550928 |
| 40 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.26004279 |
| 41 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.23618702 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.21388501 |
| 43 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.20606814 |
| 44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.19580104 |
| 45 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.17360225 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.16957341 |
| 47 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.14937894 |
| 48 | Tuberculosis_Homo sapiens_hsa05152 | 1.13734158 |
| 49 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.12483384 |
| 50 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.12436279 |
| 51 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.12019027 |
| 52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.11505246 |
| 53 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.10920311 |
| 54 | Salmonella infection_Homo sapiens_hsa05132 | 1.10258054 |
| 55 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.09365633 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.08282349 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.07272903 |
| 58 | Phototransduction_Homo sapiens_hsa04744 | 1.06843923 |
| 59 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.06424170 |
| 60 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.06367333 |
| 61 | Galactose metabolism_Homo sapiens_hsa00052 | 1.04227448 |
| 62 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.03101007 |
| 63 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.03093677 |
| 64 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02107241 |
| 65 | Leishmaniasis_Homo sapiens_hsa05140 | 1.00888785 |
| 66 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.99872217 |
| 67 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.98725954 |
| 68 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.96886449 |
| 69 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.96121345 |
| 70 | Metabolic pathways_Homo sapiens_hsa01100 | 0.95828181 |
| 71 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.95389084 |
| 72 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.94120278 |
| 73 | Shigellosis_Homo sapiens_hsa05131 | 0.93929461 |
| 74 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.93447342 |
| 75 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.93411096 |
| 76 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.92137019 |
| 77 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.90441868 |
| 78 | Allograft rejection_Homo sapiens_hsa05330 | 0.90334430 |
| 79 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.89589216 |
| 80 | Pertussis_Homo sapiens_hsa05133 | 0.86438267 |
| 81 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.85781887 |
| 82 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.79047545 |
| 83 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.77674754 |
| 84 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.77517030 |
| 85 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.76829945 |
| 86 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.73734060 |
| 87 | Lysosome_Homo sapiens_hsa04142 | 0.73101425 |
| 88 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.73100316 |
| 89 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.71111819 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.70925712 |
| 91 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.70109451 |
| 92 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.70104399 |
| 93 | Malaria_Homo sapiens_hsa05144 | 0.68248692 |
| 94 | Asthma_Homo sapiens_hsa05310 | 0.67188317 |
| 95 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.67093380 |
| 96 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.66656188 |
| 97 | Phagosome_Homo sapiens_hsa04145 | 0.66031995 |
| 98 | Carbon metabolism_Homo sapiens_hsa01200 | 0.62959276 |
| 99 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.61807241 |
| 100 | Purine metabolism_Homo sapiens_hsa00230 | 0.56547823 |
| 101 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.56005557 |
| 102 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.55750764 |
| 103 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55492307 |
| 104 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.55426766 |
| 105 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.53684090 |
| 106 | Mineral absorption_Homo sapiens_hsa04978 | 0.52485475 |
| 107 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51647322 |
| 108 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.50988995 |
| 109 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.50891120 |
| 110 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.50582274 |
| 111 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47599228 |
| 112 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.46759528 |
| 113 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45193214 |
| 114 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.44975412 |
| 115 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.43563642 |
| 116 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.42540253 |
| 117 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.42105275 |
| 118 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.42059596 |
| 119 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.41743357 |
| 120 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.37901259 |
| 121 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.33133043 |
| 122 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.32996946 |
| 123 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.32897007 |

